(R) -Lansoprazole Dexlansoprazole CAS 138530-94-6 Intende 98.0~ 102.0% (HPLC)

Description:

Nomen chemicum: (R) -Lansoprazole

Synonyma: Dexlansoprazole

CAS: 138530-94-6

Intenta: 98.0~ 102.0% (HPLC, %w/w)

Aspectus: Alba ad Off-White Crystalline pulveris

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Chemical Properties:

Nomen chemicum (R) -Lansoprazole
Synonyma R-(+)-Lansoprazole;Dexlansoprazole;2-[(R)-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole;T 168390;TAK 390;Lansoprazole De immunditia 14;Dexlansoprazole Related Impurities 2;(R) -2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-Benzimidazole;
CAS Number 138530-94-6
CATTUS Number RF-PI1916
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae C16H14F3N3O2S
M. Pondus 369.36
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Alba ad Off-White Crystalline pulveris
Solubilitas Solutum in Dimethylformamide, prope Insolubile in Aqua
Claritas & Color solutionis Meets opus est
Lepidium sativum IR Imaginum effusio ultrarubrum congruere debet cum substantia referente
Lepidium sativum HPLC Retentionis tempus praecipuum cacumen debet consentaneum esse cum illo referendi
Imprimis Rotationes +142.0°~+149.0°
Liquescens punctum ~140.0℃
Aqua Content (KF) <1.00%
Residere in Ignition <0.10%
Related immunditias (HPLC)
Nitrogen Oxides <0.10%
Sulfone <0.40%
Sulfide <0.20%
Alia alia immunditia <0.10%
Totalis immunditias <0.60%
Puritas optica (HPLC) >99.5%
Assay 98.0~ 102.0% (HPLC, %w/w, in fundamento anhydroso, libero solvendo)
Metalla gravis <10ppm
RELICTUM Solvents  
Toluene <890ppm
n-Heptane <5000ppm
Bacterial Endotoxin <2.5EU/mg
Test Standard USP Latin;Pharmacopoeia Sinica
Consuetudinem API;Oraliter Active Proton Pump Inhibitor

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

1

FAQ:

Applicatio:

(R)-Lansoprazole (CAS: 138530-94-6) est R enantiomer de Lansoprazole, Lansoprazole (AG 1749) ore activo protono inhibitor sentinae, quae prohibet stomachum ne acidum gignat.Dexlansoprazole pro Lansoprazole dextroisomer, est quaedam pharmaca anti peptici ulceris pro derivatis benzimidazolis substitutis, in structura hypothetica in elementum fluorinum, secundum sentinam protonom inhibitores omeprazole post.Dexlansoprazole effectum habet inhibitionis secretionis acidi gastrici, melior effectus quam aliorum medicamentorum (Omeprazole, Pantoprazole, Rebela, Tetrazolium) eventum ulceris significanter inhibere potest.Praestat famotidine vel Omeprazole ob damnum alcoholis inductum mucosae gastrici et ulceris duodeni maxime ex hypersecretione acidorum causatorum.Praeterea productum eundem effectum pylori anti Helicobacteri cum praeparatione bismuthi habet et pro refluxu esophagitis et Zhuo AI syndrome adhibetur.Takeda pharmaceutica approbationem dexlansoprazoli accepit, dualis emissio formula (R) -isomer lansoprazol protonis sentinae inhibitoris (PPI) iam in foro, ex FDA mense Ianuario 2009. Dexlansoprazole est capsula relaxationis morae pro curationi semel, oralis curationis. cordis aestus cum refluxu gastroesophagico symptomatico non-erosivo (GERD), sanatio esophagitis erosive (EE) et conservatione sanatae EE.

Epistulam tuam hic scribe et mitte nobis